Novel kinase platform for the validation of the anti-tubercular activities of Pelargonium sidoides (Geraniaceae).
Anti-tubercular
Kinases
Mycobacterium tuberculosis
Target identification
Journal
BMC biotechnology
ISSN: 1472-6750
Titre abrégé: BMC Biotechnol
Pays: England
ID NLM: 101088663
Informations de publication
Date de publication:
29 09 2020
29 09 2020
Historique:
received:
15
08
2019
accepted:
28
08
2020
entrez:
30
9
2020
pubmed:
1
10
2020
medline:
8
9
2021
Statut:
epublish
Résumé
Pelargonium sidoides is an important traditional medicine in South Africa with a well-defined history of both traditional and documented use of an aqueous-ethanolic formulation of the roots of P. sidoides (EPs 7630), which is successfully employed for the treatment of respiratory tract infections. There is also historical evidence of use in the treatment of tuberculosis. The aim of this study was to develop a platform of Mycobacterium tuberculosis (Mtb) kinase enzymes that may be used for the identification of therapeutically relevant ethnobotanical extracts that will allow drug target identification, as well as the subsequent isolation of the active compounds. Mtb kinases, Nucleoside diphosphokinase, Homoserine kinase, Acetate kinase, Glycerol kinase, Thiamine monophosphate kinase, Ribokinase, Aspartokinase and Shikimate kinase were cloned, produced in Escherichia coli and characterized. HPLC-based assays were used to determine the enzyme activities and subsequently the inhibitory potentials of varying concentrations of a P. sidoides extract against the produced enzymes. The enzyme activity assays indicated that these enzymes were active at low ATP concentrations. The 50% inhibitory concentration (IC This study suggests P. sidoides is potentially a source of anti-tubercular compounds and the Mtb kinase platform has significant potential as a tool for the subsequent screening of P. sidoides extracts and plant extracts in general, for compound identification and elaboration by selected extract target inhibitor profiling.
Sections du résumé
BACKGROUND
Pelargonium sidoides is an important traditional medicine in South Africa with a well-defined history of both traditional and documented use of an aqueous-ethanolic formulation of the roots of P. sidoides (EPs 7630), which is successfully employed for the treatment of respiratory tract infections. There is also historical evidence of use in the treatment of tuberculosis. The aim of this study was to develop a platform of Mycobacterium tuberculosis (Mtb) kinase enzymes that may be used for the identification of therapeutically relevant ethnobotanical extracts that will allow drug target identification, as well as the subsequent isolation of the active compounds.
RESULTS
Mtb kinases, Nucleoside diphosphokinase, Homoserine kinase, Acetate kinase, Glycerol kinase, Thiamine monophosphate kinase, Ribokinase, Aspartokinase and Shikimate kinase were cloned, produced in Escherichia coli and characterized. HPLC-based assays were used to determine the enzyme activities and subsequently the inhibitory potentials of varying concentrations of a P. sidoides extract against the produced enzymes. The enzyme activity assays indicated that these enzymes were active at low ATP concentrations. The 50% inhibitory concentration (IC
CONCLUSION
This study suggests P. sidoides is potentially a source of anti-tubercular compounds and the Mtb kinase platform has significant potential as a tool for the subsequent screening of P. sidoides extracts and plant extracts in general, for compound identification and elaboration by selected extract target inhibitor profiling.
Identifiants
pubmed: 32993619
doi: 10.1186/s12896-020-00643-w
pii: 10.1186/s12896-020-00643-w
pmc: PMC7523293
doi:
Substances chimiques
Antitubercular Agents
0
EPs 7630
0
Plant Extracts
0
Phosphotransferases
EC 2.7.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
50Références
Phytomedicine. 2008 Dec;15(12):1108-16
pubmed: 18691858
BMC Struct Biol. 2005 Mar 16;5:6
pubmed: 15771780
Arch Biochem Biophys. 2011 Aug 15;512(2):135-42
pubmed: 21683681
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 2):2310-9
pubmed: 15583379
J Ethnopharmacol. 2008 Oct 28;119(3):420-33
pubmed: 18725280
DNA Repair (Amst). 2004 Nov 2;3(11):1483-92
pubmed: 15380104
Nature. 1998 Jun 11;393(6685):537-44
pubmed: 9634230
PLoS One. 2014 Jan 29;9(1):e87487
pubmed: 24489923
BMC Biochem. 2011 Jul 13;12:36
pubmed: 21749731
Expert Rev Respir Med. 2008 Aug;2(4):455-71
pubmed: 20477209
Pharmaceuticals (Basel). 2011 Oct 10;4(10):1295-1314
pubmed: 27721327
Chembiochem. 2011 May 16;12(8):1179-82
pubmed: 21538764
Enzyme Res. 2013;2013:597028
pubmed: 23662205
S Afr Med J. 2003 Dec;93(12):904-7
pubmed: 14750489
Phytomedicine. 2007;14 Suppl 6:9-17
pubmed: 17188477
J Mol Biol. 2002 Jul 19;320(4):855-81
pubmed: 12095261
BMC Res Notes. 2012 Mar 08;5:131
pubmed: 22397702
Phytomedicine. 2007;14 Suppl 6:2-4
pubmed: 17239572
J Mol Biol. 2002 Jun 7;319(3):779-89
pubmed: 12054870
PLoS One. 2015 Sep 25;10(9):e0138075
pubmed: 26406906